Researchers reviewed current evidence on the chaya plant (Cnidoscolus chayamansa), highlighting its nutritional profile, hypoglycemic activity in animal models, and potential as a complementary aid for diabetes management. While promising, safety, dosage, and interaction studies remain essential before clinical use.